EXPERT OPIN PHARMACO 潤(rùn)色咨詢

EXPERT OPINION ON PHARMACOTHERAPY

出版年份:1999 年文章數(shù):2102 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:Monthly 自引率:2.9% 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量3.90% (2022年為4.69%)
自引率
2.9 %
年文章數(shù)
2102
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):7420)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):2296次)
作者需知
暫無(wú)數(shù)據(jù)
偏重的研究方向
期刊簡(jiǎn)介
稿件收錄要求
Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1465-6566.

Expert Opinion on Pharmacotherapy (EOP) is published monthly (12 issues) in 2001, and is a unique source of peer-reviewed Drug Evaluations and Reviews. Expert Opinion on Pharmacotherapy is dedicated to the systematic evaluation and review of newly approved drugs and drug classes. Expert Opinion on Pharmacotherapy aims to provide comprehensive coverage of the emerging literature on and experience with newly approved compounds and an evaluated assessment of the likely impact of these new agents on existing pharmacotherapy of specific diseases. Expert Opinion on Pharmacotherapy focuses on new drugs and drug classes that have become available to the pharmacopoeia in the past 2 - 5 years, analysing their actual or presumptive effect on treatment guidelines. Expert Opinion on Pharmacotherapy adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.